FDA Inspection
Jubilant Draximage Inc., dba Jubilant RadiopharmaJubilant Draximage Inc., dba Jubilant Radiopharma – FDA Inspection, Apr 23, 2024
Record Details
This FDA Inspection record concerns Jubilant Draximage Inc., dba Jubilant Radiopharma, with an inspection on April 23, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 23, 2024
- Product Type
- Drugs
View Company Profile
ID · 54ee0de3-3111-4c44-84a9-488ea6c50f60
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1240367
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Jubilant Draximage Inc., dba Jubilant Radiopharma
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 13, 2016 | Not classified | Office of Inspections and Investigations | |
| December 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jubilant Draximage Inc., dba Jubilant Radiopharma
- FDA Inspection 1171562 - 2022-06-10
- FDA Inspection 1035441 - 2017-09-08
- FDA Inspection 1003944 - 2016-12-13
- FDA Inspection 953137 - 2015-12-17
- FDA Inspection 850564 - 2013-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.